Expanding the Toolkit: Advances in Moderate to Severe Atopic Dermatitis Series

Dr. Gil Yosipovitch is a Professor of Dermatology at the Miller School of Medicine at University of Miami, and Director of the Miami Itch Center. The Itch Center focuses on diagnosing and treating chronic itch of different types, conducting research on neuroanatomy and neurophysiology of itch in humans and animal models and developing anti pruritic drugs that target the neural system.

Dr. Jennifer Ornelas is a board-certified dermatologist and pediatric dermatologist. She has conducted translational research investigating botanical extracts as novel treatment options for acne and earned a master’s in clinical and translational research. She is passionate about working with children and adults alike and providing excellent care to all of her patients. She is committed to serving the medically underserved populations of the region and strives to provide culturally competent specialist care in her practice.

Heather Zwickey, PhD, earned a Ph.D. in Immunology and Microbiology from the University of Colorado Health Sciences Center. Dr. Zwickey went on to complete a postdoctoral fellowship and teach medical school at Yale University. At the National University of Natural Medicine in Portland, OR, Dr. Zwickey is the founder the Helfgott Research Institute and established the School of Graduate Studies, developing programs in research, nutrition, and global health among others. She currently leads an NIH funded clinical research training program. She teaches at many universities and speaks at conferences world-wide. At Helfgott Research Institute, Dr. Zwickey applies her immunology expertise to natural medicine,with specific interest in the gut-brain axis in neuroinflammation.

Dr. Vivian Shi, MD is an Associate Professor of the Department of Dermatology at the University of Arkansas for Medical Sciences (UAMS), where she directs the Eczema Clinic and Hidradenitis Suppurativa Clinic.

Dr. Shi received her undergraduate degree in physiological sciences from UCLA, and
subsequently spent a year performing research on gene regulation in pathogenic bacteria in the department of microbiology at UCLA. She learned her medical degree from the University of Illinois at Chicago. During that time, she also completed a fellowship in the Skin Immunology Laboratory. She was an integral part of the team characterizing the pathophysiology of atopic dermatitis. She then completed her internship in Internal Medicine at the University of Chicago – NorthShore Health System, followed by a dermatology residency at the University of California, Davis, where she also served as chief resident.

Dr. Shi’s research and clinical interests are in complex inflammatory skin conditions (such atopic dermatitis, hidradenitis suppurativa, and psoriasis), skin barrier repair, transepidermal drug delivery, and integrative dermatology. She has served as the principal investigator for numerous industry-sponsored and investigator-initiated clinical and translational studies. She has published over 150 peer-reviewed articles and is the editor for two reference dermatology textbooks on atopic dermatitis and hidradenitis suppurativa. She is on the Board of Directors for the Hidradenitis Suppurativa Foundation, advisory board of the National Eczema Association, and is a member of the International Eczema Council.

Dr Neal Jain is an Arizona native. He obtained his medical degree from the Medical College of Wisconsin and subsequently trained in Pediatrics at Phoenix Children’s Hospital where he served as a chief resident during 2001-2002. Both he and Dr. Shimamoto trained in Allergy, Asthma and Immunology at National Jewish Health Center and University of Colorado School of Medicine in Denver, Colorado. Dr. Jain was appointed Chief Fellow at National Jewish Health Center and was a member of the Medical Staff between 2003-2004. Prior to joining San Tan Allergy & Asthma in January 2010 , he practiced as an Allergist/Immunologist at Dean Health System in Madison, Wisconsin. Dr. Jain was also on faculty as a Professor of Medicine at the University of Wisconsin in the division of Allergy, Pulmonary, and Critical Care Medicine, where he supervised fellows in training. He has been an active member of the community serving as Medical Director for the Food Allergy Association of Wisconsin, Chair of The Wisconsin Asthma Coalition and on the Board of Directors for the National Eczema Association. Dr. Jain is President of the Arizona Allergy Society, a fellow of the American Academy of Allergy, Asthma, & Immunology and of the American Academy of Pediatrics. He is board certified by the American Board of Allergy & Immunology and Pediatrics. Dr. Jain is currently a regular contributing writer of the “House Call” segment for the magazine Living Without (http://www.livingwithout.com/) and has also been featured on a nationally syndicated television program to discuss new asthma technologies. He has authored or co-authored a number of studies published in peer-reviewed journals and continues to pursue clinical research. Dr. Jain is currently accepting new pediatric and adult patients. Outside of his professional responsibilities, Dr. Jain enjoys spending time with his family, playing doubles sand volleyball, and cooking.

Jonathan Silverberg is a Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC. He is the Director of Clinical Research and Contact Dermatitis. Dr. Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. He has extensive experience in the advanced management of atopic dermatitis, contact dermatitis, hand eczema, chronic itch, psoriasis, hidradenitis and many other chronic inflammatory skin disorders. He is also a national expert in allergy patch testing, phototesting and photopatch testing.

Dr. Silverberg’s research interests include the epidemiology of chronic and infectious diseases. He has published extensively on the epidemiology of chronic inflammatory skin diseases such as eczema, psoriasis and utoimmune blistering disorders as well infections such as COVID-19, measles, shingles, cellulitis and other skin and serious infections. Dr. Silverberg has also made major contributions to health services research, patient-reported outcome development, understanding comorbidities and burden of itch and inflammatory skin disease, advancing evidence-based dermatology, drug development, and clinical trial design. His publications include more than 1000 peer-reviewed articles, abstracts and book chapters. He is also the author of the Clinical Management of Atopic Dermatitis handbook (second edition published 2022). Dr. Silverberg is also the chair of the annual Revolutionizing Atopic Dermatitis global multidisciplinary conferences, Revolutionizing Vitiligo global conference, and Director of the Foundation for Dermatology Education.